| Predictive Role of the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib |
|
Tanoglu, Alpaslan
(Department of Gastroenterology, GATA Haydarpasa Training Hospital)
Karagoz, Ergenekon (Department of Infectious Diseases and Clinical, GATA Haydarpasa Training Hospital) |
| 1 | Qin LX, Tang ZY (2002). The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol, 8, 193-9. |
| 2 | Stotz M, Gerger A, Eisner F, et al (2013). Increased neutrophillymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer, 109, 416-21. DOI ScienceOn |
| 3 | Karaman M, Balta S, Ay SA, et al (2013). The comparative effects of valsartan and amlodipine on vWf Levels and N/L ratio in patients with newly diagnosed hypertension. Clin Exp Hypertens, 35, 516-22. DOI ScienceOn |
| 4 | Mulcahy MF (2005). Management of hepatocellular cancer. Curr Treat Options Oncol, 6, 423-35. DOI ScienceOn |
| 5 | Zheng YB, Zhao W, Liu B, et al (2013). The blood neutrophil-tolymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 14, 5527-31. 과학기술학회마을 DOI ScienceOn |
| 6 | Balta S, Cakar M, Demirkol S, Arslan Z, Akhan M (2013). Higher neutrophil to lymhocyte ratio in patients with metabolic syndrome. Clin Appl Thromb Hemost, 19, 579. DOI ScienceOn |
| 7 | Song T, Zhang W, Wu Q, Kong D, Ma W (2011). A single center experience of sorafenib in advanced hepatocellular carcinoma patients: evaluation of prognostic factors. Eur J Gastroenterol Hepatol, 23, 1233-8. DOI |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
